Conn. High Court Won't Reverse Boehringer Pradaxa Win
The Connecticut Supreme Court on Monday upheld a jury verdict in favor of Boehringer Ingelheim Pharmaceuticals Inc. on Friday in a bellwether trial over the alleged bleeding risk of its blood...To view the full article, register now.
Already a subscriber? Click here to view full article